Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Axsome Therapeutics First Quarter 2025 Conference Call and Webcast. At this time all participants are in a listen-only mode.
Posts Tagged ‘NASDAQ:AXSM’
10 Best Performing Growth Stocks in 2025
Heavy AI investments and the tariffs uncertainty have been putting pressure on the technology and growth sector.
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025
No matter the market environment, you’ll always find entertainment in the biotech space.
10 Best Performing Pharma Stocks So Far in 2025
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may...
10 Best Performing Healthcare Stocks So Far in 2025
Despite the ongoing craze surrounding the GLP-1 obesity drugs, the healthcare sector was a lagger last year.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2024 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2024 Earnings Call Transcript February 18, 2025Axsome Therapeutics, Inc. misses on earnings expectations.
Why Axsome Therapeutics (AXSM) Is Advancing Today
Axsome Therapeutics (AXSM) is climbing nearly 4% after Swiss bank UBS increased its price target on the shares to $133 from $105.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Axsome Therapeutics Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Jim Cramer Thinks Axsome Therapeutics Inc (NASDAQ:AXSM) Stock Can Double
We recently published a list of Jim Cramer Latest Portfolio: 10 Stocks to Buy and Sell. Since Axsome Therapeutics Inc (NASDAQ:AXSM) ranks 4th on the list, it deserves a deeper...
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2024 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2024 Earnings Call Transcript August 5, 2024Axsome Therapeutics, Inc. misses on earnings expectations.
Jim Cramer Latest Portfolio: 10 Stocks to Buy and Sell
Jim Cramer in his latest program talked about how the China factor is affecting US stocks.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.44233 EPS, expectations were $-1.2. Axsome Therapeutics, Inc.
Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript
Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-2.08 EPS, expectations were $-1.21. Axsome Therapeutics, Inc.
11 Best Upside Stocks To Buy Right Now
In this piece, we will take a look at the 11 best upside stocks to buy right now.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2023 Earnings Call Transcript
Operator: Good morning and welcome to Axsome Therapeutics Third Quarter 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
30 Happiest Countries in the World
In this piece, we will take a look at the 30 happiest countries in the world.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Axsome Therapeutics Second Quarter Results Conference Call and Webcast.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2023 Earnings Call Transcript
Operator: Hello and welcome to the Axsome Therapeutics First Quarter 2023 Financial Results Conference Call and Webcast.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the Axsome Therapeutics Conference Call. Currently, all participants are in listen-only mode.
Wall Street Analysts are Recommending These 10 Stocks in September
In this article, we will take a look at the 10 stocks recommended by analysts in September.
Top 10 Gainers on Friday
Sportswear retailer Foot Locker, Inc. (NYSE:FL), entertainment conglomerate Warner Bros. Discovery, Inc.
15 Small Company Stocks You Should Own Now for the Next Decade
In this article, we discuss 15 small company stocks you should own now for the next decade.
5 Biotech Stocks Popular On Reddit
In this article, we discuss the 5 biotech stocks popular on Reddit.
5 Best 52-Week Low Stocks to Buy Now
In this article, we discuss the 5 best 52-week low stocks to buy now.
Were Hedge Funds Right About Dumping Axsome Therapeutics, Inc. (AXSM)?
In this article we will analyze whether Axsome Therapeutics, Inc.
Billionaire Steve Cohen’s Top 10 Small-Cap Stock Picks
In this article we presented billionaire Steve Cohen's top 10 small-cap stock picks.
Billionaire Steve Cohen’s Top 5 Small-Cap Stock Picks
In this article we discuss the billionaire Steve Cohen's top 5 small-cap stock picks.
Is AXSM A Good Stock To Buy Now?
In this article we are going to use hedge fund sentiment as a tool and determine whether Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a good investment right now.
Hedge Funds Keep Piling Into Axsome Therapeutics, Inc. (AXSM)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Were Hedge Funds Right About Axsome Therapeutics, Inc. (AXSM)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Axsome Therapeutics, Inc. (AXSM): Are Hedge Funds Done Buying?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On Axsome Therapeutics, Inc. (AXSM)
We hate to say this but, we told you so.
Did Hedge Funds Drop The Ball On Axsome Therapeutics, Inc. (AXSM)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Hedge Funds Have Never Been This Bullish On Axsome Therapeutics, Inc. (AXSM)
Is Axsome Therapeutics, Inc.
Hedge Fund and Insider Trading News: Kyle Bass, Cliff Asness, Crispin Odey, Tiger Management, Axsome Therapeutics Inc (AXSM), Alphabet Inc (GOOGL), and More
Hedge fund manager Kyle Bass, a longtime China critic, told CNBC on Monday that President Donald Trump needs to avoid striking a deal with Beijing solely for agricultural purchases...
Hedge Funds Have Never Been This Bullish On Axsome Therapeutics, Inc. (AXSM)
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
13G Filing: Sabby Capital and Axsome Therapeutics Inc (AXSM)
Sabby Healthcare Master Fund, Ltd | 0 | 704,000 | 0 | 704,000 | 704,000 | 2.76 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 05464T104 1.
